Viewing Study NCT02921802


Ignite Creation Date: 2025-12-25 @ 4:04 AM
Ignite Modification Date: 2026-01-29 @ 1:43 AM
Study NCT ID: NCT02921802
Status: COMPLETED
Last Update Posted: 2022-06-14
First Post: 2016-09-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Special Use Results Surveillance of Revlimid 5mg Capsules
Sponsor: Celgene
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module